Post-Menopause Hormone Imbalance and Cardiovascular Disease, with Erin Michos, MD, MHS
Michos discusses framing obesity as hyperandrogenism, with reductions in estrogen production contributing to higher visceral adiposity.
Related Articles
Kidney Compass: Sibeprenlimab and the VISIONARY Trial, with Vlado Perkovic, MBBS, PhD, at ERA 2025
Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.
Kidney Compass: Sibeprenlimab and the VISIONARY Trial, with Vlado Perkovic, MBBS, PhD, at ERA 2025
Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.
Revolutionizing Atopic Dermatitis
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
Comparing Screening Methods for Heart Failure in Patients with Diabetes, with Mohammad Shahzeb Khan, MD
Khan’s presentation indicates that combination screening is the optimal method of identifying heart failure risk while minimizing the percentage of cases missed.
Misconceptions About Allergy’s Connection to Atopic Dermatitis, with Anne Marie Singh, MD
This interview with Singh highlights her conference presentation on allergy and its connection to pediatric atopic dermatitis.
Revolutionizing Atopic Dermatitis
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
RaDaR Validation Confirms PARASOL Findings on FSGS Surrogate Endpoint, with Daniel Gale, PhD, MB BChir
A study presented at ERA 2025 validates the use of proteinuria as a surrogate endpoint for FSGS clinical trials.
Highlighting New FDA Approvals for Atopic Dermatitis, with Leon H. Kircik, MD
This interview highlights 3 new topical non-steroidal options for atopic dermatitis covered in Kircik’s RAD 2025 presentation on FDA approvals.
Don’t Miss a Beat: CONFIDENCE Trial and Combination T2D, CKD Therapy at Heart in Diabetes 2025
Hosts break down data from the CONFIDENCE trial on the safety and efficacy of finerenone plus empagliflozin in patients with T2D and CKD.
Kidney Compass: CONFIDENCE Trial at ERA 2025, with Rajiv Agarwal, MD, MS
Brendon Neuen, MBBS, PhD, is joined by Rajiv Agarwal, MD, MS to explore the concept of simultaneous initiation of SGLT2i and nsMRA in CKD and…
